2.66
0.12 (4.72%)
0.12 (4.72%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.11 | -4.15% | 2.54 | 2.51 | 2.69 | 2.69 | 2.65 | 00:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.53 | 2.64 | 0.11 | 4.17% | 2 | 1 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,438 | 3,844,550 | $ 2.60 | $ 9,996,562 | 5,771,348 | 1.39 - 6.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:49 | formt | 100 | $ 2.66 | USD |
Sorrento Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 453.87M | 178.69M | $ -203.54M | -1.91 | - | 74.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sorrento Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.81 | 2.8799 | 2.51 | 2.66 | 3,131,549 | -0.27 | -9.61% |
| 1 Month | 4.21 | 4.58 | 2.51 | 3.28 | 4,236,381 | -1.67 | -39.67% |
| 3 Months | 2.85 | 5.92 | 2.51 | 3.77 | 6,010,230 | -0.31 | -10.88% |
| 6 Months | 2.28 | 5.92 | 1.39 | 3.31 | 4,211,853 | 0.26 | 11.4% |
| 1 Year | 2.23 | 6.50 | 1.39 | 3.46 | 3,075,597 | 0.31 | 13.9% |
| 3 Years | 5.55 | 10.65 | 1.39 | 4.20 | 2,123,837 | -3.01 | -54.23% |
| 5 Years | 12.18 | 26.80 | 1.39 | 4.88 | 1,420,140 | -9.64 | -79.15% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
